Last reviewed · How we verify
Negative Control Toothpaste
At a glance
| Generic name | Negative Control Toothpaste |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Tooth Discolouration
- MOUTH ULCERATION
- Dental abfraction
- ORAL MUCOSAL EXFOLIATION
- MOUTH INJURY
- Mouth ulceration
- Tooth disorder
- ANGULAR CHEILITIS
- TONGUE ULCERATION
- GINGIVITIS
- Tooth fracture
- Angular cheilitis
Key clinical trials
- A Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste With a Cetylpyridinium Chloride Mouthwash in Improving Gingival Health and Reducing Plaque Accumulation (NA)
- Diagnostic Accuracy of Cold, Heat, and Electric Pulp Tests
- Intra Oral Application (IOA) Testing Study of a Stannous Toothpaste (NA)
- Intraoral Appliance (IOA) Model Evaluating the Efficacy of a Whitening Toothpaste (NA)
- Intra Oral Appliance (IOA) Model Evaluating the Efficacy of Sensitive Toothpaste (NA)
- Evaluation of a Toothpaste Containing a Gum Health Active in Participants With Gingival Problem (NA)
- Clinical Study to Evaluate the Anti-cavity Efficacy of Three Dentifrices: An In Situ Model (PHASE3)
- A Clinical Study Investigating the Effect of an Experimental Toothpaste Containing Stannous Fluoride in Improving Gingival Health (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Negative Control Toothpaste CI brief — competitive landscape report
- Negative Control Toothpaste updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI